Literature DB >> 1401210

Quantitative assessment of histological changes in chronic gastritis after eradication of Helicobacter pylori.

A Di Napoli1, R Petrino, M Boero, D Bellis, L Chiandussi.   

Abstract

AIMS: To evaluate the effect of 10 day triple treatment on H pylori eradication and associated gastritis.
METHODS: Fifty patients with H pylori positive non-ulcer dyspepsia were treated for 10 days with amoxicillin, tinidazole, and bismuth salts. Histological examination of the antral mucosa was performed before (T0), six weeks (T1), and six months (T2) after treatment. The new Sydney classification of gastritis was used, using a score from 0 to 3 to grade degree of inflammation, atrophy, activity (intraepithelial or lamina propria damage) and H pylori.
RESULTS: At T0 all patients had chronic active gastritis. Lymphoid follicules were present in 12 cases. At T1 33 patients were H pylori negative: the score showed a decrease of activity (from 2.5 to 0.54). The result was confirmed at T2 (mean score 0.22). Inflammation decreased from 1.8 to 1.4 at T2. Only one case of follicular gastritis was observed. In H pylori positive patients the scores did not show significant modifications.
CONCLUSIONS: Ten day triple treatment is effective in eradicating H pylori in 69% of cases, causing a decrease of the total score for gastritis. Activity, defined by polymorph infiltration, was promptly reduced when H pylori was eradicated. There was a trend to a reduction in inflammation, but atrophy was irreversible.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1401210      PMCID: PMC495107          DOI: 10.1136/jcp.45.9.796

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  10 in total

1.  Chronic gastritis: a clinico-pathological classification.

Authors:  P Correa
Journal:  Am J Gastroenterol       Date:  1988-05       Impact factor: 10.864

2.  Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment.

Authors:  E A Rauws; W Langenberg; H J Houthoff; H C Zanen; G N Tytgat
Journal:  Gastroenterology       Date:  1988-01       Impact factor: 22.682

3.  Patterns of physical modes of contact between Campylobacter pylori and gastric epithelium: implications about the bacterial pathogenicity.

Authors:  M Caselli; N Figura; L Trevisani; P Pazzi; P Guglielmetti; M R Bovolenta; G Stabellini
Journal:  Am J Gastroenterol       Date:  1989-05       Impact factor: 10.864

Review 4.  Campylobacter pyloridis, gastritis, and peptic ulceration.

Authors:  C S Goodwin; J A Armstrong; B J Marshall
Journal:  J Clin Pathol       Date:  1986-04       Impact factor: 3.411

5.  Lymphoid follicles in antral mucosa: immune response to Campylobacter pylori?

Authors:  M Stolte; S Eidt
Journal:  J Clin Pathol       Date:  1989-12       Impact factor: 3.411

6.  Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons.

Authors:  C P Dooley; H Cohen; P L Fitzgibbons; M Bauer; M D Appleman; G I Perez-Perez; M J Blaser
Journal:  N Engl J Med       Date:  1989-12-07       Impact factor: 91.245

7.  Screening for Campylobacter pyloridis in patients with upper dyspepsia and the relation to inflammation of the human gastric antrum.

Authors:  H Raskov; C Lanng; K Gaarslev; B F Hansen; O Hauch
Journal:  Scand J Gastroenterol       Date:  1987-06       Impact factor: 2.423

8.  Rapid urease test in the management of Campylobacter pyloridis-associated gastritis.

Authors:  B J Marshall; J R Warren; G J Francis; S R Langton; C S Goodwin; E D Blincow
Journal:  Am J Gastroenterol       Date:  1987-03       Impact factor: 10.864

9.  Ingestion of Campylobacter pyloridis causes gastritis and raised fasting gastric pH.

Authors:  A Morris; G Nicholson
Journal:  Am J Gastroenterol       Date:  1987-03       Impact factor: 10.864

10.  Campylobacter pyloridis and gastritis: association with intercellular spaces and adaptation to an environment of mucus as important factors in colonization of the gastric epithelium.

Authors:  S L Hazell; A Lee; L Brady; W Hennessy
Journal:  J Infect Dis       Date:  1986-04       Impact factor: 5.226

  10 in total
  11 in total

1.  Helicobacter pylori-negative gastritis: prevalence and risk factors.

Authors:  Helena Nordenstedt; David Y Graham; Jennifer R Kramer; Massimo Rugge; Gordana Verstovsek; Stephanie Fitzgerald; Abeer Alsarraj; Yasser Shaib; Maria E Velez; Neena Abraham; Bhupinderjit Anand; Rhonda Cole; Hashem B El-Serag
Journal:  Am J Gastroenterol       Date:  2012-11-13       Impact factor: 10.864

2.  Predictive factors and prevalence of follicular gastritis in adults with peptic ulcer and nonulcer dyspepsia.

Authors:  S D Ladas; T Rokkas; S Georgopoulos; P Kitsanta; C Liatsos; P Eustathiadou; A Karameris; C Spiliadi; S A Raptis
Journal:  Dig Dis Sci       Date:  1999-06       Impact factor: 3.199

3.  Clinical application of gastric histology to monitor treatment of dual therapy in H. pylori eradication.

Authors:  H B Yang; B S Sheu; I J Su; C H Chien; X Z Lin
Journal:  Dig Dis Sci       Date:  1997-09       Impact factor: 3.199

4.  Regulation of murine dendritic cell immune responses by Helicobacter felis antigen.

Authors:  Maureen L Drakes; Steven J Czinn; Thomas G Blanchard
Journal:  Infect Immun       Date:  2006-08       Impact factor: 3.441

5.  Improvement of gastric inflammation and resolution of epithelial damage one year after eradication of Helicobacter pylori.

Authors:  E M Witteman; M Mravunac; M J Becx; W P Hopman; J S Verschoor; G N Tytgat; R W de Koning
Journal:  J Clin Pathol       Date:  1995-03       Impact factor: 3.411

6.  Involvement of myeloid dendritic cells in the development of gastric secondary lymphoid follicles in Helicobacter pylori-infected neonatally thymectomized BALB/c mice.

Authors:  Toshiki Nishi; Kazuichi Okazaki; Kimio Kawasaki; Toshiro Fukui; Hiroyuki Tamaki; Minoru Matsuura; Masanori Asada; Tomohiro Watanabe; Kazushige Uchida; Norihiko Watanabe; Hiroshi Nakase; Masaya Ohana; Hiroshi Hiai; Tsutomu Chiba
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

7.  Gastritis in Barrett's esophagus.

Authors:  R J Mason; C G Bremner
Journal:  World J Surg       Date:  1995 Jan-Feb       Impact factor: 3.352

Review 8.  Bacterial infection as a cause of cancer.

Authors:  J Parsonnet
Journal:  Environ Health Perspect       Date:  1995-11       Impact factor: 9.031

9.  Gastritis - facts and doubts.

Authors:  Jacek Muszyński; Bartłomiej Ziółkowski; Paweł Kotarski; Adam Niegowski; Barbara Górnicka; Magdalena Bogdańska; Agnieszka Ehrmann-Jóśko; Magdalena Zemlak; Beata Młynarczyk-Bonikowska; Jolanta Siemińska
Journal:  Prz Gastroenterol       Date:  2016-09-08

10.  Significance of infectious agents in colorectal cancer development.

Authors:  Vlado Antonic; Alexander Stojadinovic; Kent E Kester; Peter J Weina; Björn Ldm Brücher; Mladjan Protic; Itzhak Avital; Mina Izadjoo
Journal:  J Cancer       Date:  2013-03-15       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.